Manning & Napier Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,105,568
| Closed | -$134M | – | 367 |
|
|
2017
Q1 | $134M | Sell |
1,105,568
-218,876
| -17% | -$26.5M | 1.04% | 40 |
|
|
2016
Q4 | $162M | Buy |
1,324,444
+1,217,834
| +1,142% | +$149M | 1.06% | 36 |
|
|
2016
Q3 | $13.1M | Buy |
106,610
+11,560
| +12% | +$1.42M | 0.08% | 96 |
|
|
2016
Q2 | $11.1M | Buy |
+95,050
| New | +$11.1M | 0.07% | 107 |
|